pharma
Amarin Neuroscience
Amarin Neuroscience Ltd
Amarin Neuroscience drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
GB HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- GB
- Programs
- 0
- Drugs
- 0
- Patents
- 11
Amarin Neuroscience pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Amarin Neuroscience drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.